Cargando…

Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial

BACKGROUND: Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone that is secreted from bone and serum level increases as renal function declines. Higher levels of FGF23 are associated with increased mortality in hemodialysis-patients and in patients with chronic kidney disease (CKD) stage 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bleskestad, Inger H, Bergrem, Harald, Hartmann, Anders, Godang, Kristin, Gøransson, Lasse G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462711/ https://www.ncbi.nlm.nih.gov/pubmed/22742720 http://dx.doi.org/10.1186/1471-2369-13-49

Ejemplares similares

Klotho and Fibroblast Growth Factor 23 Are Independent of Vitamin D, and Unlike Vitamin D, Are Not Associated With Graft- and Patient Survival After Kidney Transplantation
por: Thorsen, Inga Strand, et al.
Publicado: (2023)

Neutrophil Gelatinase-Associated Lipocalin, Fibroblast Growth Factor 23, and Soluble Klotho in Long-Term Kidney Donors
por: Thorsen, Inga Strand, et al.
Publicado: (2016)

A randomized, crossover design study of sevelamer carbonate powder and sevelamer hydrochloride tablets in chronic kidney disease patients on haemodialysis
por: Fan, Stanley, et al.
Publicado: (2009)

Linkage of Fibroblast Growth Factor 23 and Phosphate in Serum: Phosphate and Fibroblast Growth Factor 23 Reduction by Increasing Dose of Sevelamer
por: Ghorbanihaghjo, Amir, et al.
Publicado: (2018)

Glycated albumin and continuous glucose monitoring metrics across pregnancy in women with pre‐gestational diabetes
por: Toft, Johanne Holm, et al.
Publicado: (2022)

Fibroblast growth factor‐23 and parathyroid hormone suppress small intestinal magnesium absorption
por: Suksridechacin, Nasisorn, et al.
Publicado: (2022)

Parathyroid hormone and vitamin D.
por: Harrison, H. E.
Publicado: (1966)

Sevelamer Carbonate Crystal-Induced Colitis
por: Lai, T., et al.
Publicado: (2020)

Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease
por: Brito Galvao, Joao F, et al.
Publicado: (2013)

Interaction of Vitamin D with Peptide Hormones with Emphasis on Parathyroid Hormone, FGF23, and the Renin-Angiotensin-Aldosterone System
por: Latic, Nejla, et al.
Publicado: (2022)

Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor‐23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease
por: Parker, V.J., et al.
Publicado: (2017)

Fibroblast Growth Factor (FGF) 23 Regulates the Plasma Levels of Parathyroid Hormone In Vivo Through the FGF Receptor in Normocalcemia, But Not in Hypocalcemia
por: Mace, Maria L., et al.
Publicado: (2017)

Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3
por: Bouma-de Krijger, Annet, et al.
Publicado: (2019)

25-vitamin D, 1,25-vitamin D, parathyroid hormone, fibroblast growth factor-23 and cognitive function in men with advanced CKD: a veteran population
por: Jovanovich, Anna J., et al.
Publicado: (2014)

The thyroid hormone, parathyroid hormone and vitamin D associated hypertension
por: Chopra, Sandeep, et al.
Publicado: (2011)

Vitamin D and Parathyroid Hormone during Growth Hormone Treatment
por: Durá-Travé, Teodoro, et al.
Publicado: (2022)

Development and Validation of a Gas Chromatography Method for the Trace Level Determination of Allylamine in Sevelamer Hydrochloride and Sevelamer Carbonate Drug Substances
por: Kadiyala, Raju V. S. N., et al.
Publicado: (2014)

Response of different PTH assays to therapy with sevelamer or CaCO(3) and active vitamin D sterols
por: Wesseling-Perry, Katherine, et al.
Publicado: (2009)

The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol
por: Pierce, David, et al.
Publicado: (2011)

Parathyroid Hormone in Pregnancy: Vitamin D and Other Determinants
por: Hysaj, Ola, et al.
Publicado: (2021)

Prevalence of vitamin D deficiency and association with parathyroid hormone
por: Ravelo Marrero, Alejandro José, et al.
Publicado: (2022)

Ischemic Colitis in Association with Sevelamer Crystals
por: Keri, K. C., et al.
Publicado: (2019)

Gastrointestinal complications induced by sevelamer crystals
por: Yuste, Claudia, et al.
Publicado: (2017)

Comparison of Sevelamer and Calcium Carbonate in Prevention of Hypomagnesemia in Hemodialysis Patients
por: Jandaghi, Elahe, et al.
Publicado: (2021)

Sevelamer carbonate increases serum bicarbonate in pediatric dialysis patients
por: Gonzalez, Elsa, et al.
Publicado: (2010)

A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study
por: Covic, Adrian, et al.
Publicado: (2013)

Vitamin D, parathyroid hormone and metabolic syndrome – the PORMETS study
por: Raposo, Luís, et al.
Publicado: (2017)

Vitamin D and uric acid: Is parathyroid hormone the missing link?
por: Ponvilawan, Ben, et al.
Publicado: (2021)

The Effect of Vitamin D Level on Parathyroid Hormone and Alkaline Phosphatase
por: Rajab, Hussein Abdullah
Publicado: (2022)

Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis
por: Savica, Vincenzo, et al.
Publicado: (2008)

Sevelamer carbonate experience in Indian end stage renal disease patients
por: Abraham, G., et al.
Publicado: (2012)

Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3
por: Shardlow, Adam, et al.
Publicado: (2017)

Sevelamer-Induced Gastrointestinal Injury Presenting as Gastroenteritis
por: Magee, Jared, et al.
Publicado: (2018)

Sevelamer Attenuates Bioprosthetic Heart Valve Calcification
por: Meng, Zhen, et al.
Publicado: (2021)

Binding interactions with sevelamer and polystyrene sulfonate in vitro
por: van Berlo‐van de Laar, Inge R.F., et al.
Publicado: (2021)

The relationship between Fibroblast Growth Factor 23 (FGF23) and cardiac MRI findings following primary PCI in patients with acute first time STEMI
por: Thorsen, Inga Strand, et al.
Publicado: (2021)

Fibroblast growth factor 23 and parathyroid hormone predict extent of aortic valve calcifications in patients with mild to moderate chronic kidney disease
por: Di Lullo, Luca, et al.
Publicado: (2015)

Fibroblast Growth Factor 23 (FGF 23) and intact parathyroid hormone (iPTH) as markers of mineral bone disease among Nigerians with non-diabetic kidney disease
por: Raji, Yemi R, et al.
Publicado: (2022)

Vitamin D, Parathyroid Hormone and Their Associations with Hypertension in a Chinese Population
por: Li, Lihua, et al.
Publicado: (2012)

Parathyroid hormone in relation to various vitamin D metabolites in adult females
por: Al-Daghri, Nasser M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qe7r92l97nl00uio2ilt5e8sog